The New Reality for Life Sciences, by Jones Lang LaSalle
Facing pricing pressure and the need to control operating costs while boosting R&D productivity, life sciences companies are making ever-more calculated decisions about their site selections and facilities investments for R&D, sales, marketing and manufacturing, according to the Jones Lang LaSalle’s 2012 Global Life Sciences Cluster report.
Report highlights include:
- Boston remains the clear worldwide leader, with San Diego, Philadelphia and Raleigh-Durham rising in influence.
- Trend No. 1: Mergers and acquisitions and growth of middle-market life sciences companies are benefiting smaller metropolitan areas, where facilities costs are lower.
- Trend No. 2: Proximity to innovation — including intellectual capital and resources — is more important than ever for companies eagerly seeking new promising medicines.
- Trend No. 3: Build it (the lab) and they will come — some states are aggressively competing for life sciences companies as economic development drivers.
Add a Comment
We welcome your thoughtful comments. Please comply with our Community rules. All comments will display your real name.